The convergence of medicine and the digital revolution
. . . drawing on a confluence of trends that should lead us to the era of personalized medicine
Neil Seeman speculates that American cardiologist and geneticist Eric Topol might be right and uses this Wall Street Journal commentary as evidence:
Swiss drug giant Roche Holding Ltd. Tuesday made a hostile offer for Illumina Inc. that values the DNA sequencing company at $5.7 billion, in a move that underscores growing interest in the competitive field of gene sequencing.
See Neil’s review of Topol's book- N of 1 :: Longwoods.com
: In the future of medicine, the personal is less political than it is inevitable. In
The Creative Destruction of Medicine
,
American cardiologist and geneticist Eric Topol
invites us to consider the sunny side of the convergence of medicine and the digital revolution, drawing on a confluence of trends that should lead us to the era of personalized medicine.